CAMBRIDGE, MA / ACCESS Newswire / October 19, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced data regarding two of its investigational influenza candidates will be presented at IDWeek 2025, ...
CAMBRIDGE, MA / ACCESS Newswire / October 19, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced data regarding two of its investigational influenza candidates will be presented at IDWeek 2025, Octobe ...
Paul LePage wants to remove any doubt that he is fully committed to running for Congress in 2026 in the northern, ...
Studies are sounding alarm bells regarding the safety of COVID-19 mRNA vaccines, particularly in light of new findings linking these injections to an increased risk of myocarditis, a potentially fatal ...
Moderna, Inc. remains under pressure in 2025, despite recent next-gen COVID vaccine approval & cancer vaccine trial. Learn ...
Moderna's decision not to diversify outside of COVID has hurt its business substantially. The company is still generating ...
The Chosun Ilbo on MSN
Moderna's Updated COVID-19 Vaccine Targets Latest Variants
Over the past five years, 800 million people worldwide have been infected with COVID-19. The death toll has reached 7 million. Even now, deaths continue to occur. COVID-19 is now trending toward ...
It’s that time of year when the leaves are turning golden, there’s a chill in the air and the threat of respiratory viruses ...
Winter edges in and, like clockwork, Covid-19, influenza and respiratory syncytial virus step back into the ...
CAMBRIDGE, MA / ACCESS Newswire / October 16, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, November 6, 2025 to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback